carotenoid/saratani

Kiungo kimehifadhiwa kwenye clipboard

Chagua aina ya aina

Ukurasa 1 kutoka 19 matokeo

Formulation and use of carotenoids in treatment of cancer

Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala

Ingia / Ingia

BACKGROUND OF THE INVENTION The present invention relates to therapeutic compositions of carotenoids encapsulated in liposomes or other lipid carrier particles. It has been known for more than 50 years that retinoids, the family of molecules comprising both the natural and synthetic analogues of

Formulation and use of carotenoids in treatment of cancer

Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala

Ingia / Ingia

Extensively oxidized derivatives of carotenoids, retinoids and related conjugated polyenes useful as non-toxic cell-differentiation inducers, anti-proliferative agents, and anti-tumor agents

Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala

Ingia / Ingia

FIELD OF THE INVENTION This invention relates to carotenoid, retinoid and related conjugated polyene derivatives with cell-differentiation-inducing, anti-proliferative and anti-tumor properties, useful as chemotherapeutic and chemopreventive agents, and more particularly, to such derivatives

Oxidized carotenoid fractions and ketoaldehyde useful as cell-differentiation inducers, cytostatic agents, and anti-tumor agents

Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala

Ingia / Ingia

The field of this invention is fractionated oxidized carotenoid or retinoid mixtures, and individual components thereof, which are useful as cell-differentiation-inducing, anti-proliferative, anti-metastatic and anti-tumor agents. The mixtures and compounds of the invention can be used alone or in

Carotenoid agent for inhibiting the conversion of epithelial cells to tumors

Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala

Ingia / Ingia

FIELD OF THE INVENTION The invention relates to a cartenoid agent for inhibiting the conversion of epithelial cells to tumors and a method for such treatment. More particularly, the invention relates to a cartenoid agent for inhibiting the conversion of melanocytes to melanomas and a method foe such

Aqueous formulations of water-insoluble therapeutic agent comprising carotenoids and/or tocopherols

Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala

Ingia / Ingia

FIELD OF THE INVENTION The invention relates to a substantially non-toxic water dispersible therapeutic formulation including a substantially water insoluble therapeutic agent selected from the group consisting of carotenoid compositions and tocopherols that can be administered to animals, including

Method and apparatus for noninvasive measurement of carotenoids and related chemical substances in biological tissue

Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala

Ingia / Ingia

BACKGROUND OF THE INVENTION 1. The Field of the Invention The present invention relates generally to techniques for measuring levels of chemical compounds found in biological tissue. More specifically, the invention relates to a method and apparatus for the noninvasive detection and measurement of

Structural carotenoid analogs for the inhibition and amelioration of disease

Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala

Ingia / Ingia

BACKGROUND OF THE INVENTION 1. Field of the Invention The invention generally relates to the fields of medicinal and synthetic chemistry. More specifically, the invention relates to the synthesis and use of carotenoid analogs. 2. Description of the Relevant Art Cardiovascular disease (CVD), and

Structural carotenoid analogs for the inhibition and amelioration of disease

Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala

Ingia / Ingia

BACKGROUND OF THE INVENTION 1 . Field of the Invention The invention generally relates to the fields of medicinal and synthetic chemistry. More specifically, the invention relates to the synthesis and use of carotenoid analogs. 2. Description of the Relevant Art Cardiovascular disease (CVD), and

Lycopene and resveratrol compositions for NK cell activation resulting in anti-neoplastic effect

Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala

Ingia / Ingia

CROSS-REFERENCE TO RELATED APPLICATIONS This United States utility patent application is the .sctn.371 national phase of PCT international patent application no PCT/SG2010/000147, having an international filing date of Apr. 13, 2010, which claims benefit of priority to Singapore Patent Applications

Resonance Raman spectroscopy analyzer instrument for biomolecules in tissues and cells

Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala

Ingia / Ingia

BACKGROUND OF THE INVENTION 1. Field of the Invention The invention generally relates to methods of detection of cancer and, more specifically, to a Resonance Raman spectroscopy analyzer instrument for biomolecules in tissues and cells. 2. Description of Prior Art Breast cancer is one of the major

Method and compositions for preventing hormone induced adverse effects

Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala

Ingia / Ingia

FIELD OF THE INVENTION The present invention provides a method and compositions for preventing adverse effects associated with the administration of hormones such as phytoestrogens and steroidal estrogens. BACKGROUND OF THE INVENTION Hormone intake by humans can occur through, inter alia,

Protection against sunburn and skin problems with orally-ingested high-dosage zeaxanthin

Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala

Ingia / Ingia

BACKGROUND OF THE INVENTION This invention is in the field of biochemistry, pharmacology, and nutritional supplements, and relates to a new use for zeaxanthin, a carotenoid found in plants such as spinach, kale, and corn. Numerous efforts have been made to identify drugs or other biomolecules that

Process for making metabolites of lycopene

Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala

Ingia / Ingia

FIELD OF THE INVENTION The present invention is concerned with a multi-stage process for the manufacture of an oxidative metabolite of the carotenoid lycopene as well a novel intermediates produced in the manufacturing process. BACKGROUND OF THE INVENTION As is known, carotenoids, inter alia,

Micronutrient formulations for radiation applications

Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala

Ingia / Ingia

BACKGROUND OF THE INVENTION Field of the Invention This invention relates to a use of micronutrient formulations to reduce the effects of radiation on humans. Description of the Related Art Ionizing radiation (X-rays and gamma rays) has proven to be a double-edged sword in clinical Medicine since

Iliyotangulia
1
2
Ifuatayo

Jiunge na ukurasa
wetu wa facebook

Herbal & Natural Medicine

Hifadhidata kamili ya mimea ya dawa inayoungwa mkono na sayansi

Inafanya kazi katika lugha 55
Uponyaji wa mitishamba unaungwa mkono na sayansi
Kutambua mimea kwa picha
Ramani ya GPS inayoshirikiana
Soma machapisho ya kisayansi yanayohusiana na utafutaji wako
Tafuta mimea ya dawa na athari zao
Panga maslahi yako na fanya tarehe ya utafiti wa habari, majaribio ya kliniki na ruhusu

Andika dalili au ugonjwa na usome juu ya mimea ambayo inaweza kusaidia, chapa mimea na uone magonjwa na dalili ambazo hutumiwa dhidi yake.
* Habari zote zinategemea utafiti wa kisayansi uliochapishwa